Bristol (BMY) Shareholder First Financial Bank – Trust Division Lowered Its Stake by $6.79 Million as Market Valuation Declined; Tiger Legatus Capital Management Position In Yandex N V (YNDX) Was Has Raised

January 24, 2018 - By Kurt Siggers

First Financial Bank – Trust Division decreased its stake in Bristol (BMY) by 65.07% based on its latest 2017Q3 regulatory filing with the SEC. First Financial Bank – Trust Division sold 107,846 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 57,883 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.69 million, down from 165,729 at the end of the previous reported quarter. First Financial Bank – Trust Division who had been investing in Bristol for a number of months, seems to be less bullish one the $103.82B market cap company. The stock increased 0.24% or $0.15 during the last trading session, reaching $63.43. About 6.46 million shares traded or 13.81% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 24, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.

Jesse Ro increased its stake in Yandex N V (YNDX) by 7.5% based on its latest 2017Q3 regulatory filing with the SEC. Tiger Legatus Capital Management Llc bought 30,000 shares as the company’s stock rose 15.61% with the market. The hedge fund run by Jesse Ro held 430,000 shares of the programming company at the end of 2017Q3, valued at $14.17M, up from 400,000 at the end of the previous reported quarter. Tiger Legatus Capital Management Llc who had been investing in Yandex N V for a number of months, seems to be bullish on the $12.39 billion market cap company. The stock increased 0.16% or $0.06 during the last trading session, reaching $38.03. About 1.77M shares traded. Yandex N.V. (NASDAQ:YNDX) has risen 50.13% since January 24, 2017 and is uptrending. It has outperformed by 33.43% the S&P500.

Among 9 analysts covering Yandex N.V. (NASDAQ:YNDX), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Yandex N.V. had 21 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Buy” rating by Deutsche Bank on Tuesday, October 6. The firm has “Hold” rating given on Tuesday, August 4 by Zacks. Citigroup downgraded Yandex N.V. (NASDAQ:YNDX) on Friday, May 6 to “Neutral” rating. The firm has “Hold” rating given on Friday, April 7 by Standpoint Research. The rating was maintained by Deutsche Bank with “Buy” on Friday, July 14. The stock of Yandex N.V. (NASDAQ:YNDX) earned “Buy” rating by Deutsche Bank on Wednesday, October 25. The company was upgraded on Tuesday, November 17 by Morgan Stanley. The company was upgraded on Wednesday, September 16 by Goldman Sachs. The company was downgraded on Friday, September 11 by Citigroup. The rating was upgraded by Citigroup to “Buy” on Monday, March 14.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It increased, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Allsquare Wealth Mngmt Ltd Liability Co reported 2,100 shares. Morgan Stanley, a New York-based fund reported 14.09 million shares. Cap Rech holds 1.13M shares. Kidder Stephen W has 5,000 shares. Raab Moskowitz Asset Management Limited Liability Corporation holds 1.58% in Bristol-Myers Squibb Company (NYSE:BMY) or 53,220 shares. Rockefeller Fin Serv has 324,719 shares for 0.39% of their portfolio. Alexandria Ltd Com, a Virginia-based fund reported 801 shares. Gamco Investors Et Al stated it has 467,867 shares or 0.18% of all its holdings. Cetera Advsrs Ltd Limited Liability Company stated it has 70,835 shares. Fairfield Bush & stated it has 17,796 shares or 0.35% of all its holdings. 10,065 are held by Cibc Bank & Trust Usa. Strategic Ltd Liability holds 36,674 shares or 1.01% of its portfolio. Btr Cap reported 4,703 shares stake. Focused Wealth Mngmt Inc, a New York-based fund reported 14,403 shares. Moreover, Apg Asset Mngmt Nv has 0.17% invested in Bristol-Myers Squibb Company (NYSE:BMY).

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, July 10 by Cowen & Co. The company was downgraded on Monday, October 16 by Jefferies. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Buy” rating given on Tuesday, September 20 by Citigroup. The rating was upgraded by Guggenheim on Wednesday, December 2 to “Buy”. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Equal-Weight” rating by Barclays Capital on Friday, October 13. The company was maintained on Friday, August 19 by UBS. The firm has “Market Perform” rating given on Monday, January 25 by BMO Capital Markets. Robert W. Baird initiated Bristol-Myers Squibb Company (NYSE:BMY) on Wednesday, April 26 with “Outperform” rating. The rating was maintained by UBS with “Buy” on Friday, April 29. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Neutral” rating given on Monday, May 23 by Hilliard Lyons.

Since September 6, 2017, it had 1 buy, and 2 selling transactions for $646,385 activity. Another trade for 5,300 shares valued at $335,172 was sold by Lynch Thomas J. Jr.. 4,000 Bristol-Myers Squibb Company (NYSE:BMY) shares with value of $249,187 were bought by Samuels Theodore R. II.

First Financial Bank – Trust Division, which manages about $590.72 million US Long portfolio, upped its stake in Celgene Corp Com (NASDAQ:CELG) by 7,413 shares to 26,270 shares, valued at $3.83M in 2017Q3, according to the filing. It also increased its holding in Accenture Plc Ie Ireland (NYSE:ACN) by 2,382 shares in the quarter, for a total of 49,187 shares, and has risen its stake in Ishares (EFA).

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>